Annual EPS
-$3.57
+$0.71+16.59%
31 December 2023
Summary:
Inhibikase Therapeutics annual earnings per share is currently -$3.57, with the most recent change of +$0.71 (+16.59%) on 31 December 2023. During the last 3 years, it has fallen by -$1.47 (-70.00%). IKT annual EPS is now -177.13% below its all-time high of -$1.29, reached on 31 December 2018.IKT EPS Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Quarterly EPS
-$0.65
+$0.01+1.52%
30 September 2024
Summary:
Inhibikase Therapeutics quarterly earnings per share is currently -$0.65, with the most recent change of +$0.01 (+1.52%) on 30 September 2024. Over the past year, it has increased by +$0.10 (+13.33%). IKT quarterly EPS is now -157.63% below its all-time high of -$0.25, reached on 30 June 2020.IKT Quarterly EPS Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
TTM EPS
-$3.13
+$0.10+3.10%
30 September 2024
Summary:
Inhibikase Therapeutics TTM earnings per share is currently -$3.13, with the most recent change of +$0.10 (+3.10%) on 30 September 2024. Over the past year, it has increased by +$0.56 (+15.18%). IKT TTM EPS is now -201.40% below its all-time high of -$1.04, reached on 31 March 2019.IKT TTM EPS Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
IKT EPS Performance
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | +16.6% | +13.3% | +15.2% |
| 3 y3 years | -70.0% | +39.8% | +35.6% |
| 5 y5 years | -177.1% | -5.9% | -2.5% |
IKT EPS High & Low
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3 years | -70.0% | +26.5% | at high | +45.8% | at high | +39.3% |
| 5 y | 5 years | -177.1% | +26.5% | -157.6% | +58.3% | -149.3% | +39.3% |
| alltime | all time | -177.1% | +26.5% | -157.6% | +58.3% | -201.4% | +39.3% |
Inhibikase Therapeutics EPS History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sept 2024 | - | -$0.65(-1.5%) | -$3.13(-3.1%) |
| June 2024 | - | -$0.66(-9.6%) | -$3.23(-8.0%) |
| Mar 2024 | - | -$0.73(-33.0%) | -$3.51(-6.6%) |
| Dec 2023 | -$3.57(-16.6%) | -$1.09(+45.3%) | -$3.76(+1.9%) |
| Sept 2023 | - | -$0.75(-20.2%) | -$3.69(-7.8%) |
| June 2023 | - | -$0.94(-4.1%) | -$4.00(-3.8%) |
| Mar 2023 | - | -$0.98(-3.9%) | -$4.16(-2.3%) |
| Dec 2022 | -$4.28(-11.9%) | -$1.02(-3.8%) | -$4.26(-4.1%) |
| Sept 2022 | - | -$1.06(-3.6%) | -$4.44(-0.4%) |
| June 2022 | - | -$1.10(+1.9%) | -$4.46(-4.7%) |
| Mar 2022 | - | -$1.08(-10.0%) | -$4.68(-9.3%) |
| Dec 2021 | -$4.86 | -$1.20(+11.1%) | -$5.16(+6.2%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sept 2021 | - | -$1.08(-18.2%) | -$4.86(+15.8%) |
| June 2021 | - | -$1.32(-15.4%) | -$4.20(+34.1%) |
| Mar 2021 | - | -$1.56(+73.3%) | -$3.13(+64.9%) |
| Dec 2020 | -$2.10(-38.7%) | -$0.90(+115.0%) | -$1.90(+51.2%) |
| Sept 2020 | - | -$0.42(+66.0%) | -$1.26(-13.4%) |
| June 2020 | - | -$0.25(-22.9%) | -$1.45(-44.2%) |
| Mar 2020 | - | -$0.33(+27.3%) | -$2.60(-21.5%) |
| Dec 2019 | -$3.42(+165.7%) | -$0.26(-58.1%) | -$3.31(+8.4%) |
| Sept 2019 | - | -$0.61(-56.2%) | -$3.05(+25.1%) |
| June 2019 | - | -$1.40(+35.0%) | -$2.44(+135.0%) |
| Mar 2019 | - | -$1.04 | -$1.04 |
| Dec 2018 | -$1.29 | - | - |
FAQ
- What is Inhibikase Therapeutics annual earnings per share?
- What is the all time high annual EPS for Inhibikase Therapeutics?
- What is Inhibikase Therapeutics annual EPS year-on-year change?
- What is Inhibikase Therapeutics quarterly earnings per share?
- What is the all time high quarterly EPS for Inhibikase Therapeutics?
- What is Inhibikase Therapeutics quarterly EPS year-on-year change?
- What is Inhibikase Therapeutics TTM earnings per share?
- What is the all time high TTM EPS for Inhibikase Therapeutics?
- What is Inhibikase Therapeutics TTM EPS year-on-year change?
What is Inhibikase Therapeutics annual earnings per share?
The current annual EPS of IKT is -$3.57
What is the all time high annual EPS for Inhibikase Therapeutics?
Inhibikase Therapeutics all-time high annual earnings per share is -$1.29
What is Inhibikase Therapeutics annual EPS year-on-year change?
Over the past year, IKT annual earnings per share has changed by +$0.71 (+16.59%)
What is Inhibikase Therapeutics quarterly earnings per share?
The current quarterly EPS of IKT is -$0.65
What is the all time high quarterly EPS for Inhibikase Therapeutics?
Inhibikase Therapeutics all-time high quarterly earnings per share is -$0.25
What is Inhibikase Therapeutics quarterly EPS year-on-year change?
Over the past year, IKT quarterly earnings per share has changed by +$0.10 (+13.33%)
What is Inhibikase Therapeutics TTM earnings per share?
The current TTM EPS of IKT is -$3.13
What is the all time high TTM EPS for Inhibikase Therapeutics?
Inhibikase Therapeutics all-time high TTM earnings per share is -$1.04
What is Inhibikase Therapeutics TTM EPS year-on-year change?
Over the past year, IKT TTM earnings per share has changed by +$0.56 (+15.18%)